联邦贸易委员会（FTC）颠覆Express Scripts模式：里程碑式和解协议将迫使 信诺 集团（Cigna Group）旗下Express Scripts基于净价（而非标价）计算患者费用，传递终端销售回扣并提高透明度，加速向“净价药品渠道”转型。
As pharmacy benefit managers (PBMs) face more scrutiny about their practices and rising drug costs, Express Scripts unveiled new solutions last week that aim to improve price transparency and drive ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果